Molecular Templates Inc
NASDAQ:MTEM
Balance Sheet
Balance Sheet Decomposition
Molecular Templates Inc
Current Assets | 16.8m |
Cash & Short-Term Investments | 11.5m |
Receivables | 250k |
Other Current Assets | 5m |
Non-Current Assets | 18.6m |
PP&E | 16.6m |
Other Non-Current Assets | 2.1m |
Current Liabilities | 17.3m |
Accounts Payable | 1.5m |
Accrued Liabilities | 6.8m |
Other Current Liabilities | 9m |
Non-Current Liabilities | 13.9m |
Other Non-Current Liabilities | 13.9m |
Balance Sheet
Molecular Templates Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
8
|
10
|
2
|
59
|
88
|
86
|
25
|
25
|
32
|
12
|
|
Cash Equivalents |
8
|
10
|
2
|
59
|
88
|
86
|
25
|
25
|
32
|
12
|
|
Short-Term Investments |
50
|
39
|
0
|
0
|
10
|
40
|
69
|
118
|
29
|
0
|
|
Total Receivables |
7
|
2
|
0
|
0
|
5
|
8
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
4
|
7
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
1
|
3
|
0
|
2
|
2
|
7
|
7
|
5
|
7
|
5
|
|
Total Current Assets |
67
|
53
|
2
|
60
|
105
|
140
|
101
|
148
|
68
|
17
|
|
PP&E Net |
1
|
0
|
0
|
2
|
7
|
28
|
33
|
28
|
26
|
17
|
|
PP&E Gross |
1
|
0
|
0
|
2
|
7
|
28
|
33
|
28
|
26
|
17
|
|
Accumulated Depreciation |
2
|
3
|
0
|
0
|
1
|
3
|
7
|
14
|
21
|
27
|
|
Intangible Assets |
0
|
0
|
1
|
27
|
27
|
0
|
1
|
1
|
1
|
1
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
9
|
0
|
0
|
|
Other Long-Term Assets |
1
|
0
|
0
|
1
|
2
|
5
|
4
|
6
|
3
|
1
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
68
N/A
|
54
-21%
|
3
-94%
|
90
+2 816%
|
140
+55%
|
174
+24%
|
140
-20%
|
192
+38%
|
98
-49%
|
35
-64%
|
|
Liabilities | |||||||||||
Accounts Payable |
2
|
1
|
1
|
3
|
1
|
2
|
2
|
2
|
1
|
2
|
|
Accrued Liabilities |
9
|
10
|
1
|
3
|
5
|
16
|
15
|
12
|
11
|
7
|
|
Short-Term Debt |
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
15
|
0
|
2
|
3
|
26
|
18
|
20
|
33
|
46
|
9
|
|
Total Current Liabilities |
26
|
11
|
14
|
10
|
33
|
36
|
38
|
47
|
57
|
17
|
|
Long-Term Debt |
0
|
0
|
3
|
1
|
3
|
3
|
15
|
36
|
36
|
0
|
|
Other Liabilities |
66
|
2
|
0
|
2
|
4
|
32
|
28
|
45
|
19
|
14
|
|
Total Liabilities |
92
N/A
|
13
-86%
|
17
+33%
|
13
-23%
|
39
+200%
|
71
+81%
|
81
+13%
|
127
+57%
|
113
-11%
|
31
-72%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
373
|
329
|
40
|
65
|
95
|
164
|
269
|
352
|
445
|
453
|
|
Additional Paid In Capital |
349
|
370
|
1
|
142
|
196
|
267
|
328
|
418
|
430
|
457
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
24
N/A
|
41
N/A
|
14
N/A
|
77
N/A
|
101
+31%
|
103
+2%
|
59
-42%
|
66
+11%
|
15
N/A
|
4
N/A
|
|
Total Liabilities & Equity |
68
N/A
|
54
-21%
|
3
-94%
|
90
+2 816%
|
140
+55%
|
174
+24%
|
140
-20%
|
192
+38%
|
98
-49%
|
35
-64%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|